Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec in Aggressive Fibromatosis
NCT01137916Phase 2Completed
- Sponsor
- Heidelberg University
- Start
- Jun 2010
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in aggressive fibromatosis (AF), sponsored by Heidelberg University. Started Jun 2010; status: completed.
02
Drugs
03
Conditions
aggressive fibromatosis (AF)
Beyond the preview
Go deeper on NCT01137916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01137916.